These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Deep learning diagnostic and severity-stratification for interstitial lung diseases and chronic obstructive pulmonary disease in digital lung auscultations and ultrasonography: clinical protocol for an observational case-control study. Siebert JN; Hartley MA; Courvoisier DS; Salamin M; Robotham L; Doenz J; Barazzone-Argiroffo C; Gervaix A; Bridevaux PO BMC Pulm Med; 2023 Jun; 23(1):191. PubMed ID: 37264374 [TBL] [Abstract][Full Text] [Related]
4. The reliability of lung ultrasound in assessment of idiopathic pulmonary fibrosis. Manolescu D; Davidescu L; Traila D; Oancea C; Tudorache V Clin Interv Aging; 2018; 13():437-449. PubMed ID: 29606857 [TBL] [Abstract][Full Text] [Related]
5. Integrative Cardiopulmonary Ultrasound for Interstitial Lung Disease Assessment: Correlation between Lung Ultrasound Performance and Cardiac Involvement. Zhu WW; Li YD; Li H; Lu XZ; Kong LY; Ye XG; Cai QZ; Sun LL; Jiang W; Wang L Ultrasound Med Biol; 2017 Apr; 43(4):744-752. PubMed ID: 28073593 [TBL] [Abstract][Full Text] [Related]
6. Correlation between Chest Computed Tomography and Lung Ultrasonography in Patients with Coronavirus Disease 2019 (COVID-19). Tung-Chen Y; Martí de Gracia M; Díez-Tascón A; Alonso-González R; Agudo-Fernández S; Parra-Gordo ML; Ossaba-Vélez S; Rodríguez-Fuertes P; Llamas-Fuentes R Ultrasound Med Biol; 2020 Nov; 46(11):2918-2926. PubMed ID: 32771222 [TBL] [Abstract][Full Text] [Related]
7. CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis. Chung JH; Cox CW; Montner SM; Adegunsoye A; Oldham JM; Husain AN; Vij R; Noth I; Lynch DA; Strek ME AJR Am J Roentgenol; 2018 Feb; 210(2):307-313. PubMed ID: 29140119 [TBL] [Abstract][Full Text] [Related]
8. Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: A cross sectional analysis in ILD patients undergoing lung tissue sampling. Salisbury ML; Xia M; Murray S; Bartholmai BJ; Kazerooni EA; Meldrum CA; Martinez FJ; Flaherty KR Respir Med; 2016 Sep; 118():88-95. PubMed ID: 27578476 [TBL] [Abstract][Full Text] [Related]
9. Reversibility of clinical and computed tomographic lesions mimicking pulmonary fibrosis in a young cat. Stavri A; Masseau I; Reinero CR BMC Vet Res; 2021 Dec; 17(1):380. PubMed ID: 34886851 [TBL] [Abstract][Full Text] [Related]
10. Pulmonary rehabilitation for interstitial lung disease. Dowman L; Hill CJ; May A; Holland AE Cochrane Database Syst Rev; 2021 Feb; 2(2):CD006322. PubMed ID: 34559419 [TBL] [Abstract][Full Text] [Related]
11. Lung ultrasound compared to computed tomography detection and automated quantification of systemic sclerosis-associated interstitial lung disease: preliminary study. Mohammad Reza Beigi D; Pellegrino G; Loconte M; Landini N; Mattone M; Paone G; Truglia S; Di Ciommo FR; Bisconti I; Cadar M; Stefanantoni K; Panebianco V; Conti F; Riccieri V Rheumatology (Oxford); 2024 May; 63(5):1240-1245. PubMed ID: 37399086 [TBL] [Abstract][Full Text] [Related]
13. Assessment of interstitial lung disease in Sjögren's syndrome by lung ultrasound: a pilot study of correlation with high-resolution chest tomography. Vasco PG; de Luna Cardenal G; Garrido IM; Pinilla JM; Rodríguez GF; Mateo JJ; Ruiz DC Intern Emerg Med; 2017 Apr; 12(3):327-331. PubMed ID: 27900604 [TBL] [Abstract][Full Text] [Related]
14. Prospective machine learning CT quantitative evaluation of idiopathic pulmonary fibrosis in patients undergoing anti-fibrotic treatment using low- and ultra-low-dose CT. Koo CW; Larson NB; Parris-Skeete CT; Karwoski RA; Kalra S; Bartholmai BJ; Carmona EM Clin Radiol; 2022 Mar; 77(3):e208-e214. PubMed ID: 34887070 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of efficacy and safety of rituximab in combination with mycophenolate mofetil in patients with nonspecific interstitial pneumonia non-responding to a first-line immunosuppressive treatment (EVER-ILD): A double-blind placebo-controlled randomized trial. Bejan-Angoulvant T; Naccache JM; Caille A; Borie R; Nunes H; Ferreira M; Cadranel J; Crestani B; Cottin V; Marchand-Adam S; Respir Med Res; 2020 Nov; 78():100770. PubMed ID: 32777737 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of mediastinal lymph node enlargement in chronic interstitial lung disease. Grecuccio S; Sverzellati N; Uslenghi E; Caminati A; Pedrazzi G; Zompatori M Diagn Interv Radiol; 2021 May; 27(3):329-335. PubMed ID: 34003121 [TBL] [Abstract][Full Text] [Related]
17. Screening value of lung ultrasound in connective tissue disease related interstitial lung disease. Huang Y; Liu T; Huang S; Qiu L; Luo F; Yin G; Xie Q Heart Lung; 2023; 57():110-116. PubMed ID: 36182861 [TBL] [Abstract][Full Text] [Related]
18. Lung ultrasonography for long-term follow-up of COVID-19 survivors compared to chest CT scan. Giovannetti G; De Michele L; De Ceglie M; Pierucci P; Mirabile A; Vita M; Palmieri VO; Carpagnano GE; Scardapane A; D'Agostino C Respir Med; 2021 May; 181():106384. PubMed ID: 33839587 [TBL] [Abstract][Full Text] [Related]
19. Ultrasound evaluation of diaphragmatic function in patients with idiopathic pulmonary fibrosis: a retrospective observational study. Milesi J; Boussuges A; Habert P; Bermudez J; Reynaud-Gaubert M; Delliaux S; Bregeon F; Coiffard B Respir Res; 2023 Oct; 24(1):259. PubMed ID: 37898765 [TBL] [Abstract][Full Text] [Related]
20. Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA Corte TJ; Lancaster L; Swigris JJ; Maher TM; Goldin JG; Palmer SM; Suda T; Ogura T; Minnich A; Zhan X; Tirucherai GS; Elpers B; Xiao H; Watanabe H; Smith RA; Charles ED; Fischer A BMJ Open Respir Res; 2021 Dec; 8(1):. PubMed ID: 34969771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]